Clinical Trial Update: Evaluation of Persistence of Immunity in 4-year-old Children Previously Immunised With IPV-Al AJV (Picovax®) [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating persistence of immunity in 4-year-olds previously immunised with IPV-Al AJV (Picovax®) for poliomyelitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Poliomyelitis

Drugs mentioned

• Picovax® (IPV-Al AJV)

Snippet

Sponsor: AJ Vaccines A/S | Conditions: Poliomyelitis | Phase 4 | Status: COMPLETED